ValuEngine lowered shares of H & R Block (NYSE:HRB) from a sell rating to a strong sell rating in a research note released on Wednesday.
Several other equities research analysts have also commented on HRB. Morgan Stanley cut their price objective on H & R Block from $30.00 to $27.00 and set an equal weight rating for the company in a research note on Wednesday. They noted that the move was a valuation call. BMO Capital Markets cut their price objective on H & R Block from $29.00 to $25.00 and set a market perform rating for the company in a research note on Wednesday. BTIG Research reiterated a sell rating and set a $21.00 price objective on shares of H & R Block in a research note on Sunday, March 11th. Northcoast Research upgraded H & R Block from a neutral rating to a buy rating and cut their price objective for the stock from $25.02 to $24.69 in a research note on Monday, March 5th. Finally, Goldman Sachs Group assumed coverage on H & R Block in a research note on Tuesday, March 27th. They set a neutral rating and a $28.00 price objective for the company. Three analysts have rated the stock with a sell rating, six have issued a hold rating and two have issued a buy rating to the company. H & R Block has a consensus rating of Hold and a consensus target price of $26.21.
Best China Stocks To Invest In 2021: Aethlon Medical, Inc.(AEMD)
Aethlon Medical, Inc., incorporated on April 17, 1991, is a medical device company, which creates medical devices to address unmet therapeutic needs in infectious disease, cancer and other life-threatening conditions. The Company’s lead product is the Aethlon Hemopurifier, which is a device that selectively targets the elimination of circulating viruses and tumor-secreted exosomes that promote cancer progression. The Aethlon Hemopurifier sheds glycoproteins to treat infectious viral pathogens. In oncology indications, the Hemopurifier targets the removal of circulating exosomes, which are secreted by tumors to prevent the immune system from rejecting the tumors. Through its majority-owned subsidiary, Exosome Sciences, Inc. (Exosome), the Company is also developing exosome-based products to diagnose and monitor neurological disorders and cancer.
In addition, the Company operates under a Department of Defense contract through the Defense Advanced Research Projects Agency (DARPA), related to the development of a sepsis treatment device. The Company also operates under a second Department of Defense contract as a subcontractor. Under these contracts, the Company’s tasks include the development of a dialysis-like device to prevent sepsis, a fatal bloodstream infection. The Company is also studying the use of its Hemopurifier as a therapeutic solution against viral pathogens that are not treatable with antiviral drugs, as well as viral pathogens that have evolved to become drug resistant.
The Aethlon Hemopurifier addresses antiviral drug-resistance in Hepatitis C virus and Human Immunodeficiency Virus-infected individuals and serves as a countermeasure against viral pathogens not addressed by drug or vaccine therapies. In the Company’s clinical studies that are conducted in India, safety and efficacy observations of Hemopurifier therapy have been observed in both Hepatitis C virus and Human Immunodeficiency Virus-infected individuals. Delivery of Hemopurifier therapy can occur thro! ugh the infrastructure of continuous renal replacement therapy and dialysis instruments routinely found in hospitals and clinics. The Hemopurifier is designed to provide a spectrum mechanism to inhibit the presence of certain cancer and infectious disease related particles. Treatment with the Hempurifier lasts from three to six and one half hours in duration. The Company has conducted Hepatitis C virus treatment studies for Aethlon Hemopurifier.
In addition to treating Hepatitis C virus-infected individuals, the Company has conducted a single proof-of-principle treatment study related to the treatment of Human Immunodeficiency Virus. In the study, Hemopurifier therapy reduced viral load by around 93% in a Human Immunodeficiency Virus-Acquired Immunodeficiency Syndrome-infected individual without the administration of antiviral drug therapy.
The Company competes with Asahi Kasei Kurary Medical.
- [By Shane Hupp]
Get a free copy of the Zacks research report on Aethlon Medical (AEMD)
For more information about research offerings from Zacks Investment Research, visit Zacks.com
- [By Logan Wallace]
Aethlon Medical (NASDAQ: AEMD) is one of 23 publicly-traded companies in the “Analytical instruments” industry, but how does it contrast to its competitors? We will compare Aethlon Medical to related businesses based on the strength of its valuation, analyst recommendations, earnings, dividends, profitability, risk and institutional ownership.
Best China Stocks To Invest In 2021: SPDR Dow Jones Industrial Average ETF (DIA)
SPDR Dow Jones Industrial Average ETF Trust (the Trust) is a unit investment, which issues securities called trust units or units. The Trust seeks to provide investment results that, before expenses, generally correspond to the price and yields performance of the Dow Jones Industrial Average. The Dow Jones Industrial Average is an Index of 30 blue chip United States stocks.
- [By ]
How Traders Use It
The chart below shows weekly prices of SPDR Dow Jones Industrial Average (NYSE: DIA), an ETF that tracks the Dow Jones Industrial Average. A 52-week cycle with a bottom in October has been added to the chart. Some of the cycle lows are seen very close to bottoms in price. This simple approach only works occasionally and would not be a winning trading strategy on its own.
- [By Shane Hupp]
TRADEMARK VIOLATION NOTICE: “Beaumont Financial Partners LLC Boosts Stake in SPDR Dow Jones Industrial Average ETF Trust (DIA)” was posted by Ticker Report and is the sole property of of Ticker Report. If you are reading this news story on another domain, it was illegally copied and republished in violation of U.S. & international copyright and trademark legislation. The original version of this news story can be read at www.tickerreport.com/banking-finance/4162778/beaumont-financial-partners-llc-boosts-stake-in-spdr-dow-jones-industrial-average-etf-trust-dia.html.
Best China Stocks To Invest In 2021: Portland General Electric Company(POR)
Portland General Electric Company (PGE), incorporated on July 25, 1930, is an electric utility company. The Company is engaged in the generation, wholesale purchase, transmission, distribution and retail sale of electricity in the state of Oregon. The Company also sells electricity and natural gas in the wholesale market to utilities, brokers and power marketers. PGE’s service area allocation of approximately 4,000 square miles is located within Oregon and includes over 50 incorporated cities. The Company has approximately four natural gas-fired generating facilities, which include PW1, PW2, Beaver and Coyote Springs Unit 1 (Coyote Springs). PGE owns and operates over two wind farms, including Biglow Canyon Wind Farm (Biglow Canyon) and Tucannon River. Biglow Canyon, which is located in Sherman County, Oregon, is its renewable energy resource consisting of approximately 220 wind turbines with a total nameplate capacity of over 450 megawatts (MW). Its Tucannon River is located in southeastern Washington and consists of approximately 120 wind turbines with a total nameplate capacity of over 270 MW.
The Company’s Federal Energy Regulatory Commission (FERC)-licensed hydroelectric projects consist of Pelton/Round Butte on the Deschutes River near Madras, Oregon; approximately four plants on the Clackamas River, and over one on the Willamette River. PGE has approximately 66.67% ownership interest in the 455 MW Pelton/Round Butte hydroelectric project on the Deschutes River, with the remaining interest held by the Confederated Tribes of the Warm Springs Reservation of Oregon (Tribes). PGE has a dispatchable standby generation (DSG) program under which the Company can start, operate, and monitor customer-owned diesel-fueled standby generators when needed to support specific capacity needs. PGE owns approximately 79.5%, and is the operator of record, of the Kelso-Beaver Pipeline, which connects PW1, PW2, and Beaver to Northwest Pipeline, an interstate natural gas pipeline operating between British! Columbia and New Mexico. PGE transports natural gas on the Kelso-Beaver Pipeline for its own use under a firm transportation service agreement.
The Company has contractual access to natural gas storage in Mist, Oregon from which it can draw in the event that natural gas supplies are interrupted or if economic factors require its use. The storage facility is owned and operated by a local natural gas company and may be utilized to provide fuel to PW1, PW2, and Beaver. PGE supplements its own generation with power purchased in the wholesale market to meet its retail load requirements. PGE owns and/or has contractual rights associated with transmission lines that deliver electricity from its generation facilities to its distribution system in its service territory and also to the Western Interconnection. PGE owns an electric transmission system consisting of approximately 1,240 circuit miles, which include 286 circuit miles of 500 kilovolt (KV) line; 402 circuit miles of 230 kV line, and 551 miles of 115 kV line. The Company also has over 26,540 circuit miles of primary and secondary distribution lines that deliver electricity to its customers.
The Company has an ownership interest in approximately 15% of the capacity on the Colstrip Project Transmission facilities from the Colstrip plant in Montana to Bonneville Power Administration’s (BPA’s) transmission system, and approximately 20% of the capacity on the Pacific Northwest Intertie, a 4,800 MW transmission facility between John Day, in northern Oregon, and Malin, in southern Oregon near the California border. In addition, the Company has contractual rights to various transmission capacity, including approximately 3,105 MW of firm BPA transmission on BPA’s system to PGE’s service territory in Oregon, and 150 MW of firm BPA transmission from the Mid-Columbia projects in Washington to the northern end of the Pacific Northwest AC Intertie, near John Day, Oregon, five MW to Tucannon River, and five MW to Biglow Canyon. The Company o! ffers dif! ferent pricing options, including a daily market price option, various time-of-use options and several renewable energy options, which are offered to residential and small commercial customers. Its residential customers include single family housing, multiple family housing (such as apartments, duplexes, and town homes), mobile homes, and small farms. Its commercial customers consist of non-residential customers.
- [By Stephan Byrd]
Portland General Electric (NYSE:POR) and RED ELECTRICA C/ADR (OTCMKTS:RDEIY) are both utilities companies, but which is the better investment? We will compare the two companies based on the strength of their earnings, profitability, valuation, institutional ownership, dividends, risk and analyst recommendations.
- [By Shane Hupp]
Mizuho reiterated their buy rating on shares of Portland General Electric (NYSE:POR) in a research report report published on Thursday. They currently have a $50.00 price target on the utilities provider’s stock.
- [By Motley Fool Transcribers]
Portland General Electric Co (NYSE:POR)Q4 2018 Earnings Conference CallFeb. 15, 2019, 11:00 a.m. ET
Prepared Remarks Questions and Answers Call Participants